Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,767 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05246098Recruiting
Rehabilitation program study for young and adult ICU COVID/respiratory survivors
This study looks at whether a rehabilitation approach improves recovery outcomes for people who survived COVID-19 or a serious breathing infection and needed ICU/PICU care. It may help those still dealing with physical or functional problems after their critical illness.
Calgary, AlbertaAges Any age - NCT05257538Recruiting
Stool transplant to treat early C. difficile infection
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
TurkuAges 18–120 - NCT05262010RecruitingPhase 3
HPV vaccine study for Chinese women, ages 9–45
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
Hechi, GuangxiAges 18–45 - NCT05282095Recruiting
Study how HPV changes affect outcomes in CIN2
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
Fuzhou, FujianAges Up to 45 years - NCT05284877Recruiting
Study of HPV and skin cancer after organ transplant
This study looks at how human papillomavirus (HPV) and skin cancer behave in people who have had a solid organ transplant. It also includes healthy people for comparison, to understand what might be different after transplant and immune medicines.
Copenhagen NV, Capital RegionAges 18 years+ - NCT05302531RecruitingPhase 1
Testing high-absorption antibiotics for short-bowel syndrome
This early (Phase 1) study tests how well certain antibiotics get absorbed in the body when you have short-bowel syndrome. It may help doctors choose antibiotics that work better through the mouth for people with this digestion problem.
Vandœuvre-lès-Nancy, LorraineAges 18 years+ - NCT05303337Recruiting
Study of gut and HIV changes after switching to long-acting shots
This trial compares how HIV “reservoirs,” inflammation, and the gut microbiome change when people switch from daily HIV pills to long-acting injectable treatment. It may help you and your team understand what to expect with the switch and how your body responds.
MarseilleAges 18 years+ - NCT05320835Recruiting
Talk-based overdose prevention for people using opioids
This trial tests an overdose prevention approach for people who have used opioids recently. It aims to help reduce the risk of overdose by offering a structured prevention intervention.
Baltimore, MarylandAges 18 years+ - NCT05330923Recruiting
HIV and fatty liver check-in study with ultrasound follow-up
This study follows people with HIV who also have fatty liver disease and checks their health over time. It may help by improving monitoring and care planning, especially using ultrasound scans and regular follow-up.
Beijing, Beijing MunicipalityAges Any age - NCT05331118Recruiting
Study of complications and long-term outcomes after major surgery
This study follows people after planned, higher-risk surgery to learn what complications happen and how patients do long-term. It may help doctors predict risks and improve care for people having similar operations.
UtrechtAges 18 years+ - NCT05332067RecruitingPhase 2
Omalizumab to prevent future asthma flare-ups before they start
This trial studies whether starting omalizumab before asthma flare-ups begin can reduce how often children get worsening asthma that needs strong steroid medicine. It is for children with persistent asthma who have signs of allergic/asthma triggers and recent flare-up history.
Washington D.C., District of ColumbiaAges 6–17 - NCT05336240Recruiting
Parent-teen communication coaching for ages 9–17
This study tests a communication coaching program for parents to help them talk with their teen. It targets families with teens ages 9–17 receiving care at participating clinics.
Aurora, ColoradoAges 9–17 - NCT05359991Recruiting
Exercise study in children and teens with lung or blood conditions
This study tests how safe and effective a structured exercise program is for children and teens. It also compares results between children with sickle cell disease, cystic fibrosis, and healthy peers (and some teens after COVID-19 infection).
Irvine, CaliforniaAges 10–17 - NCT05361603Recruiting
Screening for hepatitis B, C, and HIV at the same time
This trial tests how acceptable it is for people who use services outside traditional clinics to be screened for hepatitis B, hepatitis C, and HIV during the same visit. If you join, you would be asked to participate and provide consent for the screening process.
Limoges, Haute VienneAges 18 years+ - NCT05371353Recruiting
Study of how long HPV vaccine immunity lasts
This study checks how well the HPV (cancer-preventing) vaccine protection stays in your body over time. It may help confirm the vaccine’s “long-lasting” immune response and guide future vaccination confidence.
Yangchun, GuangdongAges 9–45 - NCT05373758Recruiting
Help for people whose HIV treatment is not working
This trial tests different ways to manage “virologic failure,” meaning HIV viral load stays high while taking TLD (a common HIV medicine combination). It may help people better control the virus and improve treatment results, especially in parts of sub-Saharan Africa.
DurbanAges 15 years+ - NCT05378139Recruiting
At-home and hospital wireless monitoring for worsening health
This trial tests a system that continuously checks vital signs (like heart rate and breathing) using wireless sensors and sends automatic alerts if you seem to be getting worse. It may help clinicians spot problems sooner whether you’re being monitored at home or around a major surgery hospital stay.
Copenhagen, CopenhagenAges 18 years+ - NCT05387304Recruiting
Follow-up study for people with COVID infection in Shanghai
This study follows people in Shanghai who have tested positive for the COVID virus, even if they have no symptoms yet. It helps doctors understand what happens after infection and in people who later get a diagnosis.
ShanghaiAges Any age - NCT05389904Recruiting
Prevent C. difficile infection in high-risk hospital patients
This trial tests whether giving prevention right away can stop C. difficile infection from developing in people identified as high risk after a VRE swab. It may help reduce stomach infection and serious complications during hospital stay.
Boston, MassachusettsAges 18 years+ - NCT05406037Recruiting
Testing blood and tissue markers for invasive mucormycosis
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
Lille, Hauts-de-FranceAges 3–64 - NCT05418868RecruitingPhase 1
Long-acting cabotegravir injection safety in healthy adults
This Phase 1 study tests how the body handles a long-acting (slow-release) cabotegravir injection combined with a drug called hyaluronidase. It also checks safety and side effects in healthy adults to help future HIV-prevention or treatment plans.
Orlando, FloridaAges 18–55 - NCT05421325RecruitingPhase 2
Vaccine-like immune treatment to prevent lung infections in seniors
This Phase 2 study tests a site-specific immune “booster” in people age 65 and older to help improve natural immunity and reduce respiratory (lung/airway) infections. You may be eligible if you can consent, are in an eligible living situation, and are not currently using certain immune-suppressing medicines.
Burnaby, British ColumbiaAges 65 years+ - NCT05431101Recruiting
Absorbable versus non-absorbable stitches after carpal tunnel surgery
This study compares two types of stitches used to close the skin after carpal tunnel release surgery. It may help show which stitch type leads to better healing and comfort afterward.
ApeldoornAges 18 years+ - NCT05432336Recruiting
Testing better lab diagnosis for serious eye infections
This study looks at how doctors collect and test eye infection samples to get more accurate results, especially in serious cases like corneal abscess or deep eye infection. If you have signs of a complex eye infection and a sample is needed, this trial may help improve the way diagnosis is done for patients like you.
Paris, IDFAges 18 years+
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,767 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.